All Viruses articles – Page 15
-
FeaturesEvolution of the Infectious pancreatic necrosis virus and its potential reemergence
Infectious pancreatic necrosis (IPN) virus has long been a persistent threat to aquaculture, particularly the salmonid industry. Could the evolutionary fitness of IPNV, governed by quasi-species theory and high mutation rates, lead to a new outbreak.
-
NewsBovine H5N1 influenza from infected worker transmissible and lethal in animal models
A highly pathogenic avian influenza H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment.
-
NewsExperts develop laboratory toolkit for patients with viral hemorrhagic fevers such as Marburg virus disease
New resource provides guidance for healthcare facilities to perform basic laboratory testing in a safe and effective manner for patients at risk for Viral Hemorrhagic Fevers.
-
NewsVaccinating children for mpox would significantly reduce deaths in the DRC
Vaccinating children under five-years-old in endemic mpox regions in the Democratic Republic of the Congo (DRC) would significantly reduce the number of deaths in the country, according to a new analysis.
-
NewsPolar bears’ exposure to pathogens is increasing as their environment changes
As the Arctic warms, polar bears now face a greater risk of contracting several pathogens than bears three decades ago, a new study reveals.
-
NewsNovel antibody platform tackles viral mutations
Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.
-
NewsMERS coronavirus vaccine tested as safe and effective in phase Ib clinical trial
The safety, immunogenicity and optimal dosing regimen of the MVA-MERS-S vaccine candidate have been investigated in a phase Ib study in healthy individuals who were previously infected with SARS-CoV-2.
-
NewsMajor antimicrobial power boost as phages form into surprising flower shapes
Researchers treated bacteria-eating viruses so they could be viewed alive under an electron microscope and coaxed them to join together into flower-like shapes - discovering that this made them 100 times more efficient.
-
NewsStudy uncovers how Covid-19 is so good at defeating the innate immune response
The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell’s innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses.
-
NewsAncient viral DNA in human genome linked to multiple sclerosis and amyotrophic lateral sclerosis
New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous system.
-
NewsStudy reveals insights into oral HPV incidence and risks in men across 3 countries
A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil - the virus is linked to up to 90% of all oropharyngeal cancer cases in men in the U.S.
-
NewsIdentifying the genes that viruses ‘steal’ from ocean microbes
The microbes that cycle nutrients in the ocean don’t do the work on their own – the viruses that infect them also influence the process.
-
NewsPart of the GBHSH community in Spain uses doxycycline to prevent STIs
Researchers have carried out the first study in Spain on the use of DoxyPEP as a preventive strategy among the gay, bisexual and other men who have sex with men (GBHSH) community in Spain.
-
FeaturesTackling Norovirus with an improved disinfection system
Norovirus, also known in popular media as the ‘winter vomiting bug’ or ‘two-bucket winter bug’, is a highly infectious non-enveloped RNA virus that is a major cause of acute and chronic gastroenteritis.
-
NewsNew international research alliance to tackle Mpox epidemic in Africa
MpoxVax AFRIVAC is a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.
-
NewsPhages could replace harmful pesticides with a cleaner, greener alternative
Use of phage therapy in farming could be valuable in replacing chemical pesticides with a safer and greener alternative, helping to address climate change, according to a new review in Sustainable Microbiology.
-
NewsLong-term low-dose antiviral treatment benefits patients with eye disease and pain from shingles
Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new research.
-
NewsBig data study finds RSV vaccine highly effective in protecting older adults
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
-
NewsCOVID study reveals virus-induced inflammation during pregnancy, redefines vertical transmission
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
-
NewsMpox vaccine is safe and generates a robust antibody response in adolescents
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.